Not finding it? Sign in to also search OpenAlex live.
-
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status2021 Clinical Epigenetics article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Philipp Sebastian Jurmeister, Karsten Ernst Weber, Sonia Lorena Villegas, Thomas Karn, Michael Untch, Anne Thieme, +14 more
5citations -
Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer
Subarnarekha Chatterji, Marko van Treeck, Chiara Maria Lavinia Loeffler, Oliver Lester Saldanha, Gregory Patrick Veldhuizen, Didem Çifçi, +4 more
8citations -
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging2023 International Journal of Molecular Sciences article Chemistry Mass Spectrometry Techniques and Applications Open access cited by 1 patent
Juliana Pereira Lopes Gonçalves, Christine Bollwein, Aurelia Noske, Anne Jacob, Paul Jank, Sibylle Loibl, +13 more
14citations -
Deep learning models predicting hormone receptor status in breast cancer trained on females do not generalize to males: further evidence of sex-based disparity in breast cancer
Subarnarekha Chatterji, Jan Niehues, Marko van Treeck, Chiara Maria Lavinia Loeffler, Oliver Lester Saldanha, Gregory Patrick Veldhuizen, +5 more
0citations -
Abstract PS1-12-19: Disease natural history and care quality assessment of hormone receptor positive / human epidermal growth factor receptor 2 negative metastatic breast cancer (HR+/HER2- mBC) - an international multicentric study2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Stelios Theophanous, L. Revie, O. Bouissou, François P. Duhoux, Prabash Galgane Banduge, Ananya Choudhury, +18 more
0citations -
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial2024 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +11 more
6citations -
Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL
Marc Thill, Mark‐Oliver Zahn, Anja Welt, Arnd Nusch, Matthias R. Zaiss, Kathrin Engelken, +11 more
7citations -
Breastfeeding After Hormone Receptor–Positive Breast Cancer: Results From the POSITIVE Trial2025 Journal of Clinical Oncology article Medicine Breastfeeding Practices and Influences Open access
Fedro Alessandro Peccatori, Samuel M. Niman, Ann H. Partridge, Monica Ruggeri, Marco Angelo Colleoni, Cristina Saura, +28 more
7citations -
DIRECT2: A randomized phase III trial with a fasting mimicking diet program to improve chemotherapy in patients with hormone receptor positive, HER2-negative breast cancer—A Dutch Breast Cancer Research Group study (BOOG).2023 Journal of Clinical Oncology conference-abstract Medicine Dietary Effects on Health Open access
Nadia de Gruil, Gerrit‐Jan Liefers, Sanne B. Schagen, Elma Meershoek‐Klein Kranenbarg, Marielle E. Veen-Lievaart, Chris Hinnen, +12 more
1citations -
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance2024 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Mieke Van Bockstal, Jelle Wesseling, Esther H. Lips, Marjolein L. Smidt, Christine Galant, Carolien H. M. van Deurzen
11citations -
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET2023 Journal of Nuclear Medicine article Medicine Medical Imaging Techniques and Applications Open access
David A. Mankoff, Soňa Balogová, Lisa K. Dunnwald, Farrokh Dehdashti, E.F.J. deVries, Laura Evangelista, +5 more
39citations -
The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration2021 Cancer Reports article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sirus Djahansouzi, Bettina Hanstein, Daniel Rein, Michel Clees, Werner H. Rath
8citations -
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer2024 British journal of surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Florien J G van Amstel, Cornelis Maarten de Mooij, Janine M. Simons, Cristina Mitea, P. J. van Diest, Patricia Joan Nelemans, +29 more
6citations -
Retrospektive deskriptive Analyse der Subgruppe „No specific molecular pattern“ (NSMP) des Endometriumkarzinoms2026 Geburtshilfe und Frauenheilkunde conference-paper Medicine Endometrial and Cervical Cancer Treatments
Y Polt, Elisa Sieghartsleitner, Gerda Trutnovsky, Friederike Stroisch, F. Geissler, M Schmidt, +6 more
0citations -
Abstract PS11-16: Rare patients in routine care: Treatment and outcome in advanced invasive lobular breast cancer in the prospective German research platform OPAL2021 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Marc Thill, Mark‐Oliver Zahn, Anja Welt, Elmar Stickeler, Arnd Nusch, Thomas J. Fietz, +8 more
0citations -
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer2020 Therapeutic Advances in Medical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ulrike Anneliese Nitz, Oleg Gluz, Hans Heinrich Kreipe, Matthias Christgen, Sherko Küemmel, Frederick L. Baehner, +16 more
46citations -
The prognostic performance of PREDICT+ in patients (pts) with HER2-positive (HER2+) early-stage breast cancer (EBC).2021 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Georges Aftimos, Noam Falbel Ponde, Christian Maurer, +14 more
1citations -
Impact of TROP-2 and its cellular localization on prognosis of breast cancer in the GAIN cohort2024 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Christina Carolin Westhoff, Sabine Schmatloch, Rolf‐Peter Henke, Paul Jank, Akira Hattesohl, Peter Andreas Fasching, +13 more
0citations -
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL2023 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
M.A.M. Thill, Mark‐Oliver Zahn, Anja Welt, Elmar Stickeler, Arnd Nusch, Thomas J. Fietz, +7 more
11citations -
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study
Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Mireille J. M. Broeders, Luc J. A. Strobbe, Monique E.M.M. Bos, +14 more
153citations -
Novel assays monitoring direct glucocorticoid receptor protein activity exhibit high predictive power for ligand activity on endogenous gene targets2022 Biomedicine & Pharmacotherapy article Biochemistry, Genetics and Molecular Biology Estrogen and related hormone effects Open access
Laura Van Moortel, Jonathan Thommis, Brecht Maertens, Dorien Clarisse, Delphine De Sutter, Claude Libert, +4 more
20citations